CY1118746T1 - Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων - Google Patents

Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων

Info

Publication number
CY1118746T1
CY1118746T1 CY20171100317T CY171100317T CY1118746T1 CY 1118746 T1 CY1118746 T1 CY 1118746T1 CY 20171100317 T CY20171100317 T CY 20171100317T CY 171100317 T CY171100317 T CY 171100317T CY 1118746 T1 CY1118746 T1 CY 1118746T1
Authority
CY
Cyprus
Prior art keywords
compounds
phosphlatin
composition
cleaning methods
preparation
Prior art date
Application number
CY20171100317T
Other languages
Greek (el)
English (en)
Inventor
Wayne D. Luke
Steffen Jost
Original Assignee
Phosplatin Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosplatin Therapeutics Llc filed Critical Phosplatin Therapeutics Llc
Publication of CY1118746T1 publication Critical patent/CY1118746T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20171100317T 2012-05-24 2017-03-13 Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων CY1118746T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651200P 2012-05-24 2012-05-24
PCT/US2013/031885 WO2013176764A1 (en) 2012-05-24 2013-03-15 Synthetic and purification methods for phosphaplatin compounds and uses thereof

Publications (1)

Publication Number Publication Date
CY1118746T1 true CY1118746T1 (el) 2018-03-07

Family

ID=49624225

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100317T CY1118746T1 (el) 2012-05-24 2017-03-13 Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων
CY20191101227T CY1122316T1 (el) 2012-05-24 2019-11-21 Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατiνης και χρησεις αυτων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20191101227T CY1122316T1 (el) 2012-05-24 2019-11-21 Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατiνης και χρησεις αυτων

Country Status (18)

Country Link
US (2) US8846964B2 (enExample)
EP (2) EP2855496B1 (enExample)
JP (1) JP5833795B2 (enExample)
CN (2) CN106967124B (enExample)
CY (2) CY1118746T1 (enExample)
DK (2) DK3202769T3 (enExample)
ES (2) ES2619412T3 (enExample)
HR (2) HRP20170416T1 (enExample)
HU (2) HUE032197T2 (enExample)
IN (1) IN2014KN02722A (enExample)
LT (2) LT3202769T (enExample)
PL (2) PL3202769T3 (enExample)
PT (2) PT3202769T (enExample)
RS (2) RS59725B1 (enExample)
SI (2) SI3202769T1 (enExample)
SM (2) SMT201700168T1 (enExample)
TW (2) TWI599361B (enExample)
WO (1) WO2013176764A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201700168T1 (it) * 2012-05-24 2017-05-08 Phosplatin Therapeutics Llc Metodi di sintesi e di purificazione per composti di fosfaplatino e utilizzi degli stessi
TWI798175B (zh) * 2016-04-06 2023-04-11 美商弗斯普萊汀治療股份有限公司 磷酸鉑(phosphaplatin)液態調配物
US10668080B2 (en) 2017-01-06 2020-06-02 Phosplatin Therapeutics Llc Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers
JP7381083B2 (ja) * 2017-09-08 2023-11-15 フォスプラティン テラピューティクス インコーポレイテッド 免疫調節剤としてのホスファプラチン化合物およびその治療的使用
CN113861036B (zh) * 2021-11-08 2024-04-02 合肥工业大学 一种乙二胺高氯酸铜配合物的制备及用途
US11673904B1 (en) * 2021-12-09 2023-06-13 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Low pressure process for synthesis of Pt(PF3)4 involving a soluble intermediate and storage of obtained Pt(PF3)4
CN119822568B (zh) * 2025-02-19 2025-08-19 扬州宏鑫环保科技有限公司 一种高效纯化水制备装置及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
JP4463274B2 (ja) 2003-06-27 2010-05-19 明 小谷 ビスホスホネート錯体
RU2008135369A (ru) * 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
RU2482841C2 (ru) * 2007-05-18 2013-05-27 ТиТиАй Эллебо, Инк. Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
DK2173337T3 (da) * 2007-08-06 2014-09-15 Univ Ohio Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin
SI2575802T1 (sl) * 2010-06-04 2017-03-31 Ohio University Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka
EP2763537B1 (en) * 2011-10-05 2018-01-10 Rathindra N. Bose Efficient processes for large scale preparation of phosphaplatins antitumor agents
SMT201700168T1 (it) * 2012-05-24 2017-05-08 Phosplatin Therapeutics Llc Metodi di sintesi e di purificazione per composti di fosfaplatino e utilizzi degli stessi

Also Published As

Publication number Publication date
LT3202769T (lt) 2019-12-10
US20140024848A1 (en) 2014-01-23
HUE046327T2 (hu) 2020-03-30
TWI653237B (zh) 2019-03-11
JP2015523335A (ja) 2015-08-13
SI3202769T1 (sl) 2020-02-28
RS59725B1 (sr) 2020-01-31
CN104540839B (zh) 2017-02-22
HK1203202A1 (en) 2015-10-23
TWI599361B (zh) 2017-09-21
EP2855496A4 (en) 2015-04-08
HRP20170416T1 (hr) 2017-05-19
EP2855496A1 (en) 2015-04-08
EP2855496B1 (en) 2016-12-14
EP3202769B1 (en) 2019-10-02
US8859796B1 (en) 2014-10-14
US8846964B2 (en) 2014-09-30
WO2013176764A1 (en) 2013-11-28
PL3202769T3 (pl) 2020-03-31
SMT201900617T1 (it) 2020-01-14
ES2619412T3 (es) 2017-06-26
SI2855496T1 (sl) 2017-04-26
ES2751668T3 (es) 2020-04-01
TW201347765A (zh) 2013-12-01
US20140288321A1 (en) 2014-09-25
RS55806B1 (sr) 2017-08-31
HUE032197T2 (en) 2017-09-28
HRP20191904T1 (hr) 2020-01-24
PT3202769T (pt) 2019-10-31
IN2014KN02722A (enExample) 2015-05-08
CN106967124B (zh) 2020-03-06
SMT201700168T1 (it) 2017-05-08
DK2855496T3 (en) 2017-03-27
LT2855496T (lt) 2017-04-10
PL2855496T3 (pl) 2017-09-29
CN104540839A (zh) 2015-04-22
CN106967124A (zh) 2017-07-21
PT2855496T (pt) 2017-03-23
TW201741326A (zh) 2017-12-01
DK3202769T3 (da) 2019-10-28
EP3202769A1 (en) 2017-08-09
JP5833795B2 (ja) 2015-12-16
CY1122316T1 (el) 2021-01-27

Similar Documents

Publication Publication Date Title
CY1118746T1 (el) Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων
CY1122278T1 (el) Αντι il-36r αντισωματα
CY1123145T1 (el) Anti-cd40 αντισωματα
CL2017002283A1 (es) Formulaciones de anticuerpos y métodos (divisional de solicitud n°1081-2014)
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
CY1120438T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
EA201490357A1 (ru) Индазолы
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
EA202190619A1 (ru) Противовирусные соединения
EA201390993A1 (ru) Антитела к cd38
UA114087C2 (xx) Похідні піридину
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
UY34037A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
EA201491215A1 (ru) Несиалированные противовоспалительные полипептиды
EA201490778A1 (ru) АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201290642A1 (ru) Соединения и способы
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor